Ivim takes a comprehensive approach to obesity care and its customized patient-centric plans are carefully overseen by ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

In today’s evolving pharmaceutical environment, the fill‐finish segment stands out as a critical linchpin connecting drug ...

A federal judge has shut down compounding pharmacies from making cheaper versions of Eli Lilly’s weight loss and diabetes ...

The debate comes as the city prepares to start charging people in single-family homes for trash and recycling services — and ...

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...

Hims & Hers Health ( NYSE: HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A ...

A federal judge ended compounding pharmacies’ ability to make copies of the weight loss and diabetes drugs Zepbound and ...

On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 ...

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs.

In a somber Capitol Hill hearing Tuesday, aviation industry leaders delivered stark warnings about the nation's deteriorating ...